ProfileGDS4718 / 231322_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 61% 66% 57% 65% 62% 55% 58% 65% 60% 60% 59% 61% 55% 54% 56% 60% 58% 56% 53% 69% 64% 58% 61% 59% 60% 55% 58% 56% 65% 56% 56% 53% 65% 62% 56% 52% 58% 62% 56% 53% 61% 55% 51% 55% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.221161
GSM549102patient 115, normal, homogenized [OPG study]6.53466
GSM549104patient 119, normal, homogenized [OPG study]5.9537457
GSM549108patient 138, normal, homogenized [OPG study]6.4815965
GSM549119patient 077, normal, homogenized [OPG study]6.2813262
GSM549133patient 032, cancer, homogenized [OPG study]5.7402755
GSM549139patient 042, cancer, homogenized [OPG study]5.9867658
GSM549099patient 107, normal, homogenized [OPG study]6.4634365
GSM549109patient 139, normal, homogenized [OPG study]6.1601160
GSM549110patient 046, normal, homogenized [OPG study]6.0899660
GSM549114patient 063, normal, homogenized [OPG study]6.0198859
GSM549122patient 082, normal, homogenized [OPG study]6.2284461
GSM549134patient 033, cancer, homogenized [OPG study]5.7712555
GSM549136patient 036, cancer, homogenized [OPG study]5.712954
GSM549140patient 044, cancer, homogenized [OPG study]5.8446856
GSM549111patient 047, normal, homogenized [OPG study]6.1224260
GSM549113patient 057, normal, homogenized [OPG study]5.9559658
GSM549132patient 031, cancer, homogenized [OPG study]5.8796656
GSM549137patient 038, cancer, homogenized [OPG study]5.6596653
GSM549142patient 047, cancer, homogenized [OPG study]6.7804169
GSM549100patient 110, normal, homogenized [OPG study]6.3812964
GSM549107patient 135, normal, homogenized [OPG study]5.998258
GSM549115patient 068, normal, homogenized [OPG study]6.1857361
GSM549116patient 072, normal, homogenized [OPG study]6.0796759
GSM549120patient 078, normal, homogenized [OPG study]6.0949260
GSM549131patient 030, cancer, homogenized [OPG study]5.7628755
GSM549118patient 074, normal, homogenized [OPG study]6.032758
GSM549129patient 027, cancer, homogenized [OPG study]5.8680756
GSM549123patient 088, normal, homogenized [OPG study]6.4956565
GSM549124patient 006, cancer, homogenized [OPG study]5.8668756
GSM549126patient 015, cancer, homogenized [OPG study]5.8846856
GSM549128patient 025, cancer, homogenized [OPG study]5.6577153
GSM549103patient 117, normal, homogenized [OPG study]6.4780165
GSM549117patient 073, normal, homogenized [OPG study]6.2150862
GSM549138patient 041, cancer, homogenized [OPG study]5.8428256
GSM549141patient 045, cancer, homogenized [OPG study]5.6190452
GSM549130patient 028, cancer, homogenized [OPG study]5.9972758
GSM549101patient 111, normal, homogenized [OPG study]6.316862
GSM549105patient 128, normal, homogenized [OPG study]5.907156
GSM549106patient 134, normal, homogenized [OPG study]5.6135753
GSM549112patient 048, normal, homogenized [OPG study]6.1749861
GSM549125patient 011, cancer, homogenized [OPG study]5.8211755
GSM549127patient 024, cancer, homogenized [OPG study]5.5919651
GSM549135patient 035, cancer, homogenized [OPG study]5.7777455